Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Clinical trial NCT00137826 · COMPLETED
Trial details
- NCT number
- NCT00137826
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2007-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.